VASURI, FRANCESCO
 Distribuzione geografica
Continente #
AS - Asia 9.817
NA - Nord America 7.685
EU - Europa 5.032
AF - Africa 502
SA - Sud America 405
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 2
Totale 23.460
Nazione #
US - Stati Uniti d'America 7.565
VN - Vietnam 3.290
SG - Singapore 2.367
CN - Cina 2.202
IT - Italia 1.169
GB - Regno Unito 829
DE - Germania 707
HK - Hong Kong 671
SE - Svezia 546
FR - Francia 387
IN - India 366
BR - Brasile 304
KR - Corea 278
NL - Olanda 225
RU - Federazione Russa 218
IE - Irlanda 199
FI - Finlandia 198
CI - Costa d'Avorio 137
JP - Giappone 129
TG - Togo 109
ZA - Sudafrica 108
CH - Svizzera 104
UA - Ucraina 80
CA - Canada 73
SC - Seychelles 71
PH - Filippine 69
JO - Giordania 63
ID - Indonesia 62
EE - Estonia 57
AT - Austria 55
TH - Thailandia 54
BG - Bulgaria 51
BE - Belgio 50
BD - Bangladesh 46
AR - Argentina 38
MX - Messico 35
PK - Pakistan 35
PL - Polonia 35
TW - Taiwan 34
ES - Italia 28
NG - Nigeria 27
IQ - Iraq 23
TR - Turchia 20
UZ - Uzbekistan 19
EC - Ecuador 17
GR - Grecia 16
LT - Lituania 15
SA - Arabia Saudita 15
AU - Australia 14
EG - Egitto 14
IR - Iran 13
RO - Romania 13
CL - Cile 11
HR - Croazia 11
MY - Malesia 11
CO - Colombia 9
MA - Marocco 9
AE - Emirati Arabi Uniti 8
PT - Portogallo 8
CZ - Repubblica Ceca 7
KZ - Kazakistan 7
PS - Palestinian Territory 7
PY - Paraguay 7
TN - Tunisia 7
PE - Perù 6
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
DK - Danimarca 4
NP - Nepal 4
SI - Slovenia 4
SN - Senegal 4
VE - Venezuela 4
BO - Bolivia 3
ET - Etiopia 3
GE - Georgia 3
GH - Ghana 3
LB - Libano 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
GY - Guiana 2
HN - Honduras 2
HU - Ungheria 2
IL - Israele 2
LY - Libia 2
MD - Moldavia 2
MM - Myanmar 2
MT - Malta 2
NZ - Nuova Zelanda 2
PA - Panama 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CF - Repubblica Centrafricana 1
CM - Camerun 1
CR - Costa Rica 1
CV - Capo Verde 1
DZ - Algeria 1
Totale 23.441
Città #
Singapore 1.633
Ashburn 958
Ho Chi Minh City 866
Hanoi 734
Southend 681
Hong Kong 622
Chandler 595
Fairfield 582
Hefei 545
San Jose 420
Bologna 378
Woodbridge 301
Santa Clara 295
Houston 289
Seattle 278
Beijing 255
Seoul 249
Wilmington 246
Cambridge 235
Dallas 210
Ann Arbor 208
Princeton 207
Dublin 197
Dong Ket 186
Boardman 172
Los Angeles 167
Helsinki 150
Lauterbourg 140
Council Bluffs 138
Abidjan 137
Da Nang 112
Lomé 109
New York 109
Haiphong 108
Tokyo 105
Bern 87
Bremen 87
Munich 85
Frankfurt am Main 84
Berlin 70
Westminster 69
Milan 65
Nanjing 63
Redondo Beach 63
Amman 62
Buffalo 60
Turin 58
Padova 53
Bengaluru 51
Sofia 50
Hải Dương 49
São Paulo 49
Brussels 46
San Diego 46
Johannesburg 45
Jinan 44
Jakarta 42
Shenyang 42
Shanghai 41
Biên Hòa 37
Can Tho 37
Guangzhou 37
Orem 36
Chicago 35
Quận Bình Thạnh 34
Redmond 34
Rome 34
Thái Nguyên 34
Changsha 33
Florence 33
Nuremberg 32
Saint Petersburg 31
Montreal 30
Tongling 30
Des Moines 29
Tianjin 29
Amsterdam 28
Bắc Ninh 28
Düsseldorf 27
Hyderabad 27
Ninh Bình 27
Phoenix 26
Ha Long 25
Jacksonville 25
Warsaw 25
London 24
Paris 24
Thái Bình 24
Turku 24
Zhengzhou 24
Lappeenranta 23
Nanchang 23
Toronto 23
Vũng Tàu 23
Brooklyn 22
Bến Tre 22
Falls Church 22
Hebei 22
Medford 22
Vienna 22
Totale 15.175
Nome #
The histological assessment of liver fibrosis in grafts from extended criteria donors predicts the outcome after liver transplantation: A retrospective study 642
Gene polymorphism in tissue epidermal growth factor receptor (EGFR) influences clinical and histological vulnerability of carotid plaques 317
Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors:First Italian Clinical Trial 267
Multi-Gene Next-Generation Sequencing Panel for Analysis of BRCA1/BRCA2 and Homologous Recombination Repair Genes Alterations Metastatic Castration-Resistant Prostate Cancer 264
Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human liver aging markers sensitive to donor-recipient age-mismatch in transplants 259
Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments 238
Adenocarcinoma in Crohn's disease: the pathologist's experience in a tertiary referral centre of inflammatory bowel disease. 236
The carotid plaque as paradigmatic case of site-specific acceleration of agingprocess: The microRNAs and the inflammaging contribution 234
MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 230
Hypothermic oxygenated perfusion in extended criteria donor liver transplantation-A randomized clinical trial 229
Lifelong maintenance of composition, function and cellular/subcellular distribution of proteasomes in human liver 227
Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area 226
Histological Evidence of Diabetic Kidney Disease Precede Clinical Diagnosis 226
Membrane localization of human equilibrative nucleoside transporter 1 in tumor cells may predict response to adjuvant gemcitabine in resected cholangiocarcinoma patients 225
MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma 223
Asbestos exposure as an additional risk factor for small duct intrahepatic cholangiocarcinoma: a pilot study 216
Predictors of survival in malignant aortic tumors 214
Tissue Ki67 proliferative index expression and pathological changes in hemodialysis arteriovenous fistulae: Preliminary single-center results 212
Increased plin2 expression in human skeletal muscle is associated with sarcopenia and muscle weakness 211
Hepatopancreatoduodenectomy for locally advanced perihilar cholangiocarcinoma: A case report and a plea not to underestimate surgical resectability 210
Automatically extracted machine learning features from preoperative CT to early predict microvascular invasion in HCC: the role of the Zone of Transition (ZOT) 208
Studies on immunoproteasome in human liver. Part I: absence in fetuses, presence in normal subjects, and increased levels in chronic active hepatitis and cirrhosis 207
Different histological types of active intraplaque calcification underlie alternative miRNA-mRNA axes in carotid atherosclerotic disease 205
Assessment of liver fibrosis in trnsplant recipients with recurrent HCV infection: Usefulness of transient elastography. 202
The PPAR-γ Agonist Pioglitazone Modulates Proliferation and Migration in HUVEC, HAOSMC and Human Arteriovenous Fistula-Derived Cells 196
Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies 195
Strategies to Restore Adenosine Triphosphate (ATP) Level After More than 20 Hours of Cold Ischemia Time in Human Marginal Kidney Grafts. 192
Adventitial Microcirculation Is a Major Target of SARS-CoV-2-Mediated Vascular Inflammation 191
The Relationship between Timing of Pretransplant Kidney Biopsy, Graft Loss, and Survival in Kidney Transplantation: An Italian Cohort Study 190
In Reply 188
Immunomorphology and molecular biology of mixed primary liver cancers: is Nestin a marker of intermediate-cell carcinoma? 187
Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: Protocol for a single-center randomized controlled trial 186
Donors risk assessment in transplantation: From the guidelines to their real-world application 185
Differential expression of perilipin 2 and 5 in human skeletal muscle during aging and their association with atrophy-related genes 185
Diffuse calcifications protect carotid plaques regardless of the amount of neoangiogenesis and related histological complications 184
Dyskerin expression in human fetal, adult and neoplastic intrahepatic bile ducts: Correlations with cholangiocarcinoma aggressiveness 183
Expression pattern of perilipins in human brain during aging and in Alzheimer's disease 183
The role of 3D microenvironmental organization in MCF-7 epithelial–mesenchymal transition after 7 culture days 180
The immunoproteasome β5i subunit is a key contributor to ictogenesis in a rat model of chronic epilepsy 180
ORGAN-SPECIFIC BIOMARKERS OF HUMAN AGING: THE CASE OF LIVER 178
MicroRNA profiles of human peripheral arteries and abdominal aorta in normal conditions: MicroRNAs-27a-5p, -139-5p and -155-5p emerge and in atheroma too 175
Concomitant Heterotopic Pancreas and Endometriosis as a Rare Cause of Ileo-Ileal Intussusception in a Young Woman with Spina Bifida: Case Report and Literature Review 174
Direct antiviral treatments for hepatitis c virus have off-target effects of oncologic relevance in hepatocellular carcinoma 174
Extracellular Vesicles Derived from Mesenchymal Stromal Cells Delivered during Hypothermic Oxygenated Machine Perfusion Repair Ischemic/Reperfusion Damage of Kidneys from Extended Criteria Donors 173
MiR-199-3p replacement affects E-cadherin expression through Notch1 targeting in hepatocellular carcinoma 172
Liver collision lesion: inflammatory hepatocellular adenoma within focal nodular hyperplasia 172
Metabolic Profile of Obeticholic Acid and Endogenous Bile Acids in Rats with Decompensated Liver Cirrhosis 171
Facing the enigma of the vascular network in hepatocellular carcinomas in cirrhotic and non-cirrhotic livers. 171
Expanding the criteria of organ procurement from donors with prostate cancer: the application of the new Italian guidelines. 171
MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma 170
Histological findings of diabetic kidneys transplanted in non-diabetic recipients: a case series 170
New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: A new diagnostic algorithm 169
Standardization of conventional chemoembolization for hepatocellular carcinoma 169
Involvement of miR-30a-5p and miR-30d in Endothelial to Mesenchymal Transition and Early Osteogenic Commitment under Inflammatory Stress in HUVEC 168
Biochemical and immunomorphological evaluation of hepatocyte growth factor and c-Met pathway in patients with critical limb ischemia. 167
Frozen section analysis of unusual small testicular tumor masses: report of 3 cases 166
Plasma membrane localization of human equilibrative nucleoside transporter 1 (hENT-1) to predict better outcome of adjuvant gemcitabine in cholangiocarcinoma (CC) patients. 166
Real-time quantitative assay for routine testing of HCV RNA in formalin-fixed, paraffin-embedded liver samples. 166
Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4 165
Correlation of molecular alterations with pathological features in hepatocellular carcinoma: Literature review and experience of an Italian center 164
From large to small: the immunohistochemical panel in the diagnosis of early hepatocellular carcinoma 163
RANDOMIZED TRIAL ON HYPOTHERMIC OXYGENATED PERFUSION VS STATIC COLD STORAGE IN LIVER TRANSPLANTATION FROM EXTENDED CRITERIA DONORS: INTERIM ANALYSIS 162
Automatically Extracted Machine Learning Features from Preoperative CT to Early Predict Microvascular Invasion in HCC: The Role of the Zone of Transition (ZOT) 161
Circulating CXCL9, monocyte percentage, albumin, and C-reactive protein as a potential, non-invasive, molecular signature of carotid artery disease in 65+ patients with multimorbidity: a pilot study in Age.It 161
Tissue miRNA 483-3p expression predicts tumor recurrence after surgical resection in histologically advanced hepatocellular carcinomas 161
Rapid, marked wash out at contrast-enhanced ultrasound in nodules in cirrhosis should raise the suspicion of cholangiocarcinoma. 160
Alungamento dei vasi renali mediante allograft vascolari criopreservati: è possibile ottimizzare le problematiche tecniche nel trapianto da vivente con graft destri o vascolarizzazione anomala? 157
Role of microRNAs in the main molecular pathways of hepatocellular carcinoma 157
[68Ga]Ga-PSMA-11 PET/CT-Positive Hepatic Inflammatory Pseudotumor: Possible PSMA-Avid Pitfall in Nuclear Imaging. 156
Morpho-molecular approach (NGS plus digital PCR) in diagnosis of malignant biliary strictures 156
Author Correction: Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors: First Italian Clinical Trial (Scientific Reports, (2020), 10, 1, (6063), 10.1038/s41598-020-62979-9) 156
Revisiting the role of pathological analysis in transarterial chemoembolization-treated hepatocellular carcinoma after transplantation. 155
Renal Vessel Extension With Cryopreserved Vascular Grafts: Overcoming Surgical Pitfalls in Living Donor Kidney Transplant 155
Histopathological evaluation of recurrent hepatitis C after liver transplantation: A review 151
OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation. 151
The study of calcified atherosclerotic arteries: An alternative to evaluate the composition of a problematic tissue reveals new insight including metakaryotic cells 150
Decreasing Albumin mRNA Expression in Cholangiocarcinomas along the Bile Duct Tree. 149
Primary liver sarcomatous carcinoma: report of two cases and review of the literature. 148
Case report: Histological findings of peri-appendicitis in three children with SARS-CoV-2 – related multisystem inflammatory syndrome: A mark for systemic inflammation? 147
An ex-vivo cell model for studying intimal hyperplasia in AVF failure 147
Immunohistochemical and Ultrastructural Characterization of Telocytes in Normal and Diabetic Human Kidneys 146
Molecular alterations in proteasomes of rat liver during aging result in altered proteolytic activities. 146
Nestin and WT1 expression in atheromathous plaque neovessels: Association with vulnerability. 146
A case report of myoid gonadal stromal tumor treated with testis sparing surgery 143
The meaning of tissue and serum HCV RNA quantitation in hepatitis C recurrence after liver transplantation: A retrospective study. 143
Caveolin-1 in situ expression in glomerular and peritubular capillaries as a marker of ultrastructural progression and severity of renal thrombotic microangiopathy 142
In vitro alteration of physiological parameters do not hamper the growth of human multipotent vascular wall-mesenchymal stem cells. 142
Interpathologist concordance in the histological diagnosis of focal prostatic atrophy lesions, acute and chronic prostatitis, PIN, and prostate cancer 142
Venous outflow in partial heterotopic liver transplantation with spleen replacement: Evidence of no chronic venous hypertension 142
MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary 139
The incidence and morphology of Monckeberg's medial calcification in banked vascular segments from a monocentric donor population. 138
Periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic cancer: a pilot study 138
Decompensated cirrhosis as presentation of LKM1/LC1 positive type 2 autoimmune hepatitis in adulthood. A rare clinical entity of difficult management 136
Unusual asymptomatic presentation of bladder cancer metastatic to the penis 136
Trophism and Homeostasis of Liver Sinusoidal Endothelial Graft Cells during Preservation, with and without Hypothermic Oxygenated Perfusion 135
ETS-Related Gene Expression in Healthy Femoral Arteries With Focal Calcifications 134
Brivanib in combination with Notch3 silencing shows potent activity in tumour models 133
Morphologic and molecular diagnostic criteria of malignancies in biliary strictures. 132
The role of peritumoral CD8 + /TIA1 + lymphocytes in hepatocellular carcinoma aggressiveness and recurrence after surgical resection 131
Beyond histology: A tissue algorithm predictive of post-surgical recurrence in hepatocellular carcinomas, including TERT promoter mutation. 131
Totale 18.182
Categoria #
all - tutte 63.727
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.727


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021455 0 0 0 0 0 0 0 0 0 95 38 322
2021/20222.062 132 76 137 152 176 90 68 162 102 157 489 321
2022/20232.598 229 345 140 364 173 229 85 168 416 70 196 183
2023/2024906 96 161 60 106 68 138 39 62 40 45 38 53
2024/20253.935 210 483 349 285 409 228 287 152 93 349 313 777
2025/202610.540 1.300 1.518 950 805 913 482 1.441 325 2.145 661 0 0
Totale 23.996